Polyamine‐Responsive Morphological Transformation of a Supramolecular Peptide for Specific Drug Accumulation and Retention in Cancer Cells

Abstract The precise accumulation and extended retention of nanomedicines in the tumor tissue has been highly desired for cancer therapy. Here a novel supramolecular‐peptide derived nanodrug (SPN) that can be transformed to microfibers in response to intracellular polyamine in cancer cells for significantly enhanced tumor specific accumulation and retention is developed. The supramolecular‐peptide is constructed via the non‐covalent interactions between cucurbit[7]uril (CB[7]) and Phe on Phe‐Phe‐Val‐Leu‐Lys‐camptothecin conjugates (FFVLK‐CPT, PC). The resultant amphiphilic supramolecular complex subsequently self‐assembles into nanoparticles with a hydrodynamic diameter of 164.2 ± 3.7 nm. Upon internalization into spermine‐overexpressed cancer cells, the CB[7]‐Phe host–guest pairs can be competitively dissociated by spermine and can release free PC, which immediately form β‐sheet structures and subsequently reorganize into microfibers, leading to dramatically improved accumulation, retention, and sustained release of CPT in tumor cells for highly effective cancer therapy. Accordingly, this SPN exhibit rather low toxicity against non‐cancerous cells due to the morphological stability and fast exocytosis of the nanodrugs in those cells without abundant spermine. This study reports the first supramolecular peptide capable of polyamine‐responsive “nanoparticle‐to‐microfiber” transformation for specific tumor therapy with minimal side effects. This work also offers novel insights to the design and development of stimuli‐responsive nanomaterials as precision medicine.